To determine the efficacy and safety of injection Labetalol Versus tablet Nifedipine in patients of severe pre-eclampsia
Phase 4
- Conditions
- Health Condition 1: O141- Severe pre-eclampsia
- Registration Number
- CTRI/2024/07/071651
- Lead Sponsor
- DrRida Rizvi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Women with Viable fetus at 20 weeks of gestation or more with severe pre-eclampsia
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in hypertensive condition of the patient with minimum dose required.Timepoint: Every 10 minutes till the target BP(150/110mmHg).
- Secondary Outcome Measures
Name Time Method Adverse drug reaction of drugs.Timepoint: Every 10 minutes till the target BP(150/110mmHg).